Article

Morphine alters the locomotor responses to a D2/D3 dopamine receptor agonist differentially in adolescent and adult mice.

Behavioral and Cellular Neuroscience, Department of Psychology, Texas A&M University, College Station, TX, USA.
Journal of Psychopharmacology (impact factor: 3.04). 04/2012; 26(10):1355-65. DOI:10.1177/0269881112443741 pp.1355-65
Source: PubMed

ABSTRACT The D2-like dopamine receptors mediate the emotional/aversive state during morphine withdrawal. Given age-dependent differences in the affective responses to withdrawal, this study examined whether the response to dopamine receptor agonists is altered differentially across ages following morphine administration. Adolescent and adult mice were injected with morphine (twice daily, 10-40 mg/kg, s.c.) or saline for 6 days. Subsequently, they were examined for their locomotor response to quinpirole, a D2/D3 receptor agonist, and SKF 38393, a D1 receptor agonist. Quinpirole dose-dependently reduced locomotion in drug-naïve animals. Initial suppression was also observed in morphine-treated animals, but was followed by enhanced locomotion. Notably, this enhanced locomotion was markedly greater in adolescents than adults. Quinpirole-induced hypo-locomotion is thought to be mediated by the presynaptic D2Short receptors, whereas its activating effect is mediated by postsynaptic D2Long/D3 receptors. This suggests that following morphine administration, the postsynaptic, but not the presynaptic, dopaminergic signaling is differentially modulated across ages. This locomotor supersensitivity was not observed for SKF 38393, a D1 dopamine receptor agonist. The D2/D3 receptors are involved in the pathophysiology of many mental illnesses. Thus, this study offers a potential explanation for the increased psychiatric disorder co-morbidities when drug use begins during adolescence.

0 0
 · 
1 Bookmark
 · 
20 Views

Keywords

activating effect
 
D1 dopamine receptor agonist
 
D1 receptor agonist
 
D2-like dopamine receptors
 
D2/D3 receptor agonist
 
D2/D3 receptors
 
dopamine receptor agonists
 
dopaminergic signaling
 
following morphine administration
 
increased psychiatric disorder co-morbidities
 
mental illnesses
 
morphine administration
 
morphine withdrawal
 
morphine-treated animals
 
postsynaptic D2Long/D3 receptors
 
potential explanation
 
presynaptic D2Short receptors
 
quinpirole
 
Quinpirole dose-dependently
 
Quinpirole-induced hypo-locomotion